Thromboxane Receptor: Regulation of Platelet Function and Thrombin Generation

Target Name: Prostanoid TP receptor

NCBI ID: P6152

Prostanoid TP receptor

Other Name(s): Thromboxane receptor | TP

Thromboxane Receptor: Regulation of Platelet Function and Thrombin Generation

Propanoid TP receptor (nonspecified subtype), also known as thromboxane receptor, is a protein that plays a crucial role in the regulation of blood clotting and thrombin generation. It is a member of the TP (thromboxane) receptor family, which also includes the A2A, A2B, and A4 subtypes. The TP receptor is involved in the signaling pathway that regulates the assembly and disassembly of platelet aggregates, which are the building blocks of blood clots.

The TP receptor is a G protein-coupled receptor (GPCR), which means that it uses a protein called G protein to transmit signals to downstream effectors. The G protein is a family of transmembrane proteins that regulate various cellular processes, including cell signaling, protein synthesis, and intracellular signaling. The TP receptor is a potent modulator of platelet aggregation, which is a critical event in the formation of blood clots.

The TP receptor is composed of a extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is responsible for the binding of the TP receptor to the G protein. It consists of a long N-terminal region that contains a putative G protein-binding site, as well as a short C-terminal region that contains a catalytic domain. The transmembrane domain is responsible for the maintenance of the TP receptor's structural integrity and its ability to interact with the G protein. It is composed of a long alpha-helices that form a transmembranespan and a short beta-sheet that is involved in the formation of the transmembranespan.

The intracellular domain is responsible for the TP receptor's ability to interact with the intracellular signaling pathway. It consists of a long N-terminal region that contains a protein-coding gene, as well as a short C-terminal region that contains a catalytic domain. The catalytic domain is responsible for the TP receptor's catalytic activity and is composed of a single amino acid residue, which is a critical site for the TP receptor's catalytic activity.

The TP receptor is involved in the regulation of several physiological processes, including platelet function, thrombin generation, and blood clot formation. It is a potent modulator of platelet aggregation and has been shown to play a crucial role in the regulation of platelet function. The TP receptor is also involved in the regulation of thrombin generation, which is a critical event in the formation of blood clots.

The TP receptor is a potential drug target and has been shown to be a promising biomarker for the diagnosis and treatment of thromboembolic diseases. Several studies have shown that the TP receptor is involved in the regulation of platelet aggregation and that it is a potent modulator of platelet function. These studies have also shown that the TP receptor is involved in the regulation of thrombin generation and that it is a critical event in the formation of blood clots.

The TP receptor is also involved in the regulation of other physiological processes, including cell signaling, protein synthesis, and intracellular signaling. It is a member of the TP receptor family, which is composed of the A2A, A2B, and A4 subtypes. The A2A subtype is involved in the regulation of blood pressure, while the A2B and A4 subtypes are involved in the regulation of pain perception.

The TP receptor is a GPCR, which means that it uses a protein called G protein to transmit signals to downstream effectors. The G protein is a family of transmembrane proteins that regulate various cellular processes, including cell signaling, protein synthesis, and intracellular signaling. The TP receptor is a potent modulator of platelet aggregation, which is a critical event in the formation of blood clots.

Protein Name: Prostanoid TP Receptor (nonspecified Subtype)

The "Prostanoid TP receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Prostanoid TP receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets